• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Briacell Therapeutics Corp (NQ: BCTX )

    0.7255 -0.0446 (-5.79%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Briacell Therapeutics Corp

    < Previous 1 2 3 Next >
    Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
    Via Benzinga
    Exposures Fossil Fuels
    Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge
    Via Benzinga
    Exposures Fossil Fuels
    Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
    BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint inhibitor. 
    Via Benzinga
    Dow Tumbles 350 Points; US Inflation Rate Slows In August
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    BriaCell: An Emerging Immuno - Oncology Company
    BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer. 
    Via Talk Markets
    Exposures Product Safety
    New Treatments May Help Those With Advanced Breast Cancer Live Longer
    Via StatePoint Media
    Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer
    A look at BriaCell's research into a better treatment for prostate cancer. 
    Via Talk Markets
    BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024
    BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning! 
    Via InvestorPlace
    BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024
    BriaCell Therapeutics just reported results for the second quarter of 2024. 
    Via InvestorPlace
    Get Rich Quick With These 3 Penny Stocks to Buy Now
    Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick. 
    Via InvestorPlace
    Topics Economy
    Exposures Economy
    BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
    BriaCell Therapeutics Corp (NASDAQ: BCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients... 
    Via Benzinga
    Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
    FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food... 
    Via FinancialNewsMedia
    Exposures Product Safety
    BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
    CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment 
    Via TheNewswire.com
    BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
    FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs... 
    Via FinancialNewsMedia
    BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
    From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock... 
    Via Talk Markets
    BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer
    Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach. 
    Via Talk Markets
    BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    By Ernest Dela Aglanu, Benzinga 
    Via News Direct
    Topics Death
    Exposures Death
    BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing... 
    Via TheNewswire.com
    Topics Death
    Exposures Death
    BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX< 
    Via Benzinga
    BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs... 
    Via TheNewswire.com
    Topics Stocks
    Exposures Product Safety US Equities
    BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    By Faith Ashmore, Benzinga 
    Via News Direct
    Exposures Product Safety
    BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. 
    Via Benzinga
    IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
    From ImmunoPrecise Antibodies
    Via Business Wire
    Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
    Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. 
    Via Benzinga
    Why Is BriaCell (BCTX) Stock Moving Today?
    BriaCell Therapeutics (BCTX) stock is on the move Wednesday morning after getting Fast Track approval from the FDA for Bria-IMT. 
    Via InvestorPlace
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.